These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 21323523)
1. Prospective study of clinical and biological prognostic factors at diagnosis in patients with early stage B-cell chronic lymphocytic leukemia. Oliveira AC; de la Banda E; Domingo-Domenech E; Encuentra M; Mercadal S; Domingo A; Alonso E; Espinet B; Grau J; De Sevilla AF; Gonzalez-Barca E Leuk Lymphoma; 2011 Mar; 52(3):429-35. PubMed ID: 21323523 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality. Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229 [TBL] [Abstract][Full Text] [Related]
3. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study. Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682 [TBL] [Abstract][Full Text] [Related]
4. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma. Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211 [TBL] [Abstract][Full Text] [Related]
5. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis. Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100 [TBL] [Abstract][Full Text] [Related]
6. [Fluorescence in Situ Hybridization for Detecting Molecular Cytogenetic Abnormalities of Chronic Lymphocytic Leukemia]. Zhang HY; Yang YL; Zhao Q; Zhang J; Bai H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1474-1479. PubMed ID: 33067940 [TBL] [Abstract][Full Text] [Related]
7. Significance of zeta-associated protein (ZAP-70) and CD38 expression in chronic lymphocytic leukemia. el-Sharnouby JA; el-Shakankiri AA; Hendy OM; Ahmed LM; Taha AM Egypt J Immunol; 2006; 13(2):69-84. PubMed ID: 18689273 [TBL] [Abstract][Full Text] [Related]
8. Do biologic parameters affect the time to first treatment of clinical monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Rai stage 0? Results of a prospective analysis. Molica S; Giannarelli D; Levato L; Gentile M; Mirabelli R; Morabito F Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):e55-60. PubMed ID: 25445470 [TBL] [Abstract][Full Text] [Related]
9. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression. Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336 [TBL] [Abstract][Full Text] [Related]
10. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI. Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419 [TBL] [Abstract][Full Text] [Related]
11. Modern and conventional prognostic markers of chronic lymphocytic leukaemia in the everyday haematological practice. Doubek M; Mayer J; Obrtlíková P; Smolej L; Cmunt E; Schwarz J; Brejcha M; Kozmon P; Pospíšilová S; Brychtová Y; Pospíšil Z; Trněný M Eur J Haematol; 2011 Aug; 87(2):130-7. PubMed ID: 21535162 [TBL] [Abstract][Full Text] [Related]
12. CD38 expression in B-chronic lymphocytic leukemia: association with clinical presentation and outcome in 155 patients. Domingo-Domènech E; Domingo-Clarós A; Gonzàlez-Barca E; Beneitez D; Alonso E; Romagosa V; De Sanjos S; Petit J; Grañena A; Fernández de Sevilla A Haematologica; 2002 Oct; 87(10):1021-7. PubMed ID: 12368155 [TBL] [Abstract][Full Text] [Related]
13. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia. Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031 [TBL] [Abstract][Full Text] [Related]
14. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia. Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545 [TBL] [Abstract][Full Text] [Related]
15. Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia. Visentin A; Facco M; Frezzato F; Castelli M; Trimarco V; Martini V; Gattazzo C; Severin F; Chiodin G; Martines A; Bonaldi L; Gianesello I; Pagnin E; Boscaro E; Piazza F; Zambello R; Semenzato G; Trentin L Clin Lymphoma Myeloma Leuk; 2015 Oct; 15(10):612-20.e1-5. PubMed ID: 26233718 [TBL] [Abstract][Full Text] [Related]
16. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia. Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities. Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276 [TBL] [Abstract][Full Text] [Related]
19. Prospective validation of a risk score based on biological markers for predicting progression free survival in Binet stage A chronic lymphocytic leukemia patients: results of the multicenter O-CLL1-GISL study. Gentile M; Cutrona G; Mosca L; Matis S; Fabris S; Lionetti M; Ilariucci F; Zupo S; Musolino C; Levato L; Molica S; Di Raimondo F; Vincelli I; Di Rienzo N; Pesce EA; Angrilli F; Federico M; Neri A; Ferrarini M; Morabito F Am J Hematol; 2014 Jul; 89(7):743-50. PubMed ID: 24711230 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of soluble p53 protein in B-cell chronic lymphocytic leukemia. Del Principe MI; Del Poeta G; Venditti A; Buccisano F; Maurillo L; Marini R; Cox MC; Panetta P; Suppo G; Degan M; Bruno A; Gattei V; Amadori S Haematologica; 2004 Dec; 89(12):1468-75. PubMed ID: 15590397 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]